Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000927356-99-000829
Filing Date
1999-05-07
Accepted
1999-05-07 00:00:00
Documents
2
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO 1998 10-K 10-K/A 249701
2 CONSENT OF ERNST & YOUNG LLP EX-23.1 1042
  Complete submission text file 0000927356-99-000829.txt   252268
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
RIBOZYME PHARMACEUTICALS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27914 | Film No.: 99614346
SIC: 2834 Pharmaceutical Preparations